Catherine Skari

TIF releases new video on thalassaemia prevention

  Thalassaemia is a hereditary blood disease that CAN be prevented! But in what ways? ΤΙF’s latest educational video shines…

Read More »

TIF issues new leaflet on gene therapy for patients with β-thalassaemia and other haemoglobin disorders

  Recent scientific developments in gene therapy for β-thalassaemia have brought hope that multi-transfused β-thalassaemia patients will, in the very…

Read More »

Gene Therapy in β-Thalassaemia and Other Haemoglobin Disorders (2019)

An educational leaflet aimed at improving the awareness and comprehension of people with thalassaemia and other haemoglobinopathies worldwide about gene…

Read More »

Biotech companies issue first joint declaration on human gene editing

Companies involved in human gene editing have entered the ethical debate about the controversial technology, issuing a joint declaration that…

Read More »

World Patient Safety Day – 17 September 2019

134 million adverse events occur each year due to unsafe care in hospitals in low- and middle-income countries, contributing to…

Read More »

FAiTh – Fight Against Thalassemia Activities report 2018-19

  The ”FAiTh- Fight Against Thalassemia” patients & parents Association just published their 1st year activity report, after being officially…

Read More »

TIF Preceptorship Programme 2019

Read More »

The International Thalassaemia Day 2021 Official Page is Now Live!

INTERNATIONAL THALASSAEMIA DAY 2021 – 8 MAY  ”Addressing Health Inequalities Across the Global Thalassaemia Community” Visit the International Thalassaemia Day…

Read More »

World Hepatitis Day 2019

World Hepatitis Day (WHD) takes places every year on 28 July bringing the world together under a single theme to…

Read More »

FDA Accelerates Review Of Sickle Cell Disease Medicine Crizanlizumab

Novartis announced earlier today the FDA accepted the company’s Biologics License Application (BLA) and has granted Priority Review for its…

Read More »